Oxford BioMedica PLC
F:OXOA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
O
|
Oxford BioMedica PLC
F:OXOA
|
UK |
|
E
|
Erredue SpA
F:Z9H
|
IT |
|
C
|
ChampionsGate Acquisition Corp
NASDAQ:CHPG
|
US |
|
S
|
Softrock Minerals Ltd
XTSX:SFT
|
CA |
|
F
|
Faster Enterprises Ltd
ASX:FE8
|
AU |
|
M
|
Mustang Bio Inc
F:2W6
|
US |
|
M
|
MyTech Group Bhd
KLSE:MYTECH
|
MY |
|
HOOKIPA Pharma Inc
NASDAQ:HOOK
|
US |
|
Golden Leaf International Group Ltd
HKEX:8549
|
HK |
|
S
|
Straightup Resources Inc
CNSX:ST
|
CA |
|
Sirius Media
F:MAV
|
FR |
|
Prosper Gold Corp
XTSX:PGX
|
CA |
|
Rostelekom PAO
F:RTL
|
RU |
|
N
|
Nerds On Site Inc
SWB:3NS
|
CA |
Wall St Price Targets
OXOA Price Targets Summary
Oxford BioMedica PLC
According to Wall Street analysts, the average 1-year price target for OXOA is 10.69 EUR with a low forecast of 9.58 EUR and a high forecast of 14.19 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is OXOA's stock price target?
Price Target
10.69
EUR
According to Wall Street analysts, the average 1-year price target for OXOA is 10.69 EUR with a low forecast of 9.58 EUR and a high forecast of 14.19 EUR.
What is the Revenue forecast for Oxford BioMedica PLC?
Projected CAGR
18%
Over the last 14 years, the compound annual growth rate for Revenue has been 25%. The projected CAGR for the next 8 years is 18%.
What is the Gross Profit forecast for Oxford BioMedica PLC?
Projected CAGR
23%
Over the last 14 years, the compound annual growth rate for Gross Profit has been 17%. The projected CAGR for the next 8 years is 23%.
